Published in J Virol on September 01, 1998
Prevention of immunodeficiency virus induced CD4+ T-cell depletion by prior infection with a non-pathogenic virus. Virology (2008) 1.04
Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J Virol (2002) 0.95
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol (2000) 0.95
The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis. Front Immunol (2014) 0.94
Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol (2001) 0.93
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes. J Virol (1999) 0.92
Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes. Immunology (2000) 0.90
Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. J Virol (2002) 0.87
DNA vaccines in veterinary use. Expert Rev Vaccines (2009) 0.86
Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon. J Virol (2006) 0.85
Feline immunodeficiency virus (FIV) neutralization: a review. Viruses (2011) 0.80
Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV. Vaccine (2009) 0.78
Commercially Available Enzyme-Linked Immunosorbent Assay and Polymerase Chain Reaction Tests for Detection of Feline Immunodeficiency Virus Infection. J Vet Intern Med (2016) 0.75
An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection. Vaccine (2016) 0.75
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (1988) 11.05
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science (1992) 9.30
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science (1995) 6.30
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med (1995) 5.22
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol (1996) 3.84
Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro (1974) 2.93
Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc Natl Acad Sci U S A (1989) 2.21
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med (1997) 2.12
Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine (1993) 1.89
Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today (1996) 1.75
DNA vaccines. Curr Opin Immunol (1996) 1.74
Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol (1996) 1.71
FIV infection of the domestic cat: an animal model for AIDS. Immunol Today (1997) 1.61
Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology (1995) 1.59
Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch Virol (1989) 1.59
Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines. Intervirology (1991) 1.53
Experimental vaccine protection against feline immunodeficiency virus. AIDS Res Hum Retroviruses (1991) 1.42
Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS (1991) 1.33
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J Virol (1994) 1.32
Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol (1996) 1.29
Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J Virol (1995) 1.28
DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol (1993) 1.25
Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol (1995) 1.14
Serological responses of cats to feline immunodeficiency virus. AIDS (1990) 1.14
B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins. J Virol (1993) 1.12
Humoral and cellular immunities elicited by HIV-1 vaccination. J Pharm Sci (1996) 1.12
Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol (1995) 1.11
Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J Virol (1996) 1.08
Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol (1997) 1.08
Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J Virol (1997) 1.08
Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J Gen Virol (1994) 1.06
Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol (1992) 1.03
Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J Immunol (1996) 1.00
Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins. Res Virol (1993) 0.97
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol (1997) 0.97
Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis. J Clin Microbiol (1992) 0.94
Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res Hum Retroviruses (1995) 0.94
Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine (1996) 0.94
Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. Immunology (1995) 0.92
Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine (1996) 0.89
Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats. Vet Microbiol (1995) 0.89
Analysis of the amino terminal presequence of the feline immunodeficiency virus glycoprotein: effect of deletions on the intracellular transport of gp95. Virology (1992) 0.89
Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Res Hum Retroviruses (1997) 0.84
Simian immunodeficiency virus DNA vaccine trial in macaques. Ann N Y Acad Sci (1995) 0.83
Interferon-gamma expression in macaque lymph nodes during primary infection with simian immunodeficiency virus. Cytokine (1996) 0.83
Cytokines at the research-clinical interface: potential applications. Blood Rev (1996) 0.83
Nucleotide and predicted peptide sequence of feline interferon-gamma (IFN-gamma). DNA Seq (1995) 0.77
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (1992) 7.20
Codon and amino-acid specificities of a transfer RNA are both converted by a single post-transcriptional modification. Nature (1988) 4.17
Molecular mechanism of codon recognition by tRNA species with modified uridine in the first position of the anticodon. Proc Natl Acad Sci U S A (1985) 2.66
Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature (2000) 2.41
A cell culture model of the blood-brain barrier. J Cell Biol (1991) 2.35
Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol (1986) 2.34
Exocytosis regulates urinary acidification in turtle bladder by rapid insertion of H+ pumps into the luminal membrane. Proc Natl Acad Sci U S A (1982) 2.28
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses. Nature (1981) 2.11
Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet Rec (2001) 2.08
Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII. Virology (1981) 2.03
Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst (1973) 2.00
Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A (2001) 1.99
Early interventions in severe sepsis and septic shock: a review of the evidence one decade later. Minerva Anestesiol (2012) 1.96
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res (2001) 1.91
Acute hemorrhagic cystitis in children. Isolation of adenovirus type II. N Engl J Med (1968) 1.90
A novel lysine-substituted nucleoside in the first position of the anticodon of minor isoleucine tRNA from Escherichia coli. J Biol Chem (1988) 1.85
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol (2000) 1.76
Conformational rigidity of specific pyrimidine residues in tRNA arises from posttranscriptional modifications that enhance steric interaction between the base and the 2'-hydroxyl group. Biochemistry (1992) 1.73
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A (1997) 1.69
Architectures of class-defining and specific domains of glutamyl-tRNA synthetase. Science (1995) 1.68
Characterization of a 105,000 molecular weight gag-related phosphoprotein from cells transformed by the defective avian sarcoma virus PRCII. Virology (1981) 1.67
The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer (1978) 1.66
Determinants of the host range of feline leukaemia viruses. J Gen Virol (1973) 1.64
FIV infection of the domestic cat: an animal model for AIDS. Immunol Today (1997) 1.61
Biology of feline leukemia virus in the natural environment. Cancer Res (1976) 1.59
Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J Virol (1992) 1.59
Successful treatment of systemic lupus erythematosus and pulmonary hypertension with intravenous prostaglandin I2 followed by its oral analogue. Intern Med (2000) 1.55
Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case-control study. Eur J Cancer (1995) 1.52
A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol (1999) 1.48
Common mechanism of infection by lentiviruses. Nature (1997) 1.47
Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med (1995) 1.46
Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology (2000) 1.45
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression. AIDS (2000) 1.44
Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein. Biochemistry (1997) 1.44
Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J Immunol (1983) 1.44
Cystic schwannoma of the orbit: case report. Surg Neurol (2000) 1.43
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43
Further study on acute hemorrhagic cystitis due to adenovirus type 11. N Engl J Med (1973) 1.41
Transgenic science. Br Vet J (1994) 1.41
Vaccination against feline leukaemia virus. Vet Rec (1994) 1.39
Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis (1993) 1.36
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene (1995) 1.35
Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J Virol (1994) 1.34
Replication of cat leukemia virus in cell cultures. Nature (1968) 1.34
Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol (1992) 1.33
Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J Biol Chem (1995) 1.33
Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem (1997) 1.33
Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS (1991) 1.33
Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPVs in cats. Virology (2000) 1.32
First observation of the Greisen-Zatsepin-Kuzmin suppression. Phys Rev Lett (2008) 1.29
The pathogenicity and defectiveness of PRCII: a new type of avian sarcoma virus. Virology (1981) 1.28
Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol (Tokyo) (1997) 1.26
Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. J Natl Cancer Inst (1971) 1.25
Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology (1991) 1.25
Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene (2001) 1.25
Isolation of the nucleic acid of feline leukemia virus. Virology (1971) 1.25
Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol (1993) 1.24
A study of naturally occurring feline coronavirus infections in kittens. Vet Rec (1992) 1.24
Evidence for three classes of avian sarcoma viruses: comparison of the transformation-specific proteins of PRCII, Y73, and Fujinami viruses. Proc Natl Acad Sci U S A (1981) 1.24
Identification and cloning of two species of cadherins in bovine endothelial cells. EMBO J (1990) 1.23
Esh avian sarcoma virus codes for a gag-linked transformation-specific protein with an associated protein kinase activity. Virology (1981) 1.23
Advanced nuclear magnetic resonance lanthanide probe analyses of short-range conformational interrelations controlling ribonucleic acid structures. Biochemistry (1981) 1.23
Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci (2000) 1.23
Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch Virol (1992) 1.22
A third class of avian sarcoma viruses, defined by related transformation-specific proteins of Yamaguchi 73 and Esh sarcoma viruses. Proc Natl Acad Sci U S A (1981) 1.22
Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J Immunol (1985) 1.22
Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000. Virology (1980) 1.21
Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B. Int J Cancer (1978) 1.21
Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding. J Virol (1997) 1.21
Influence of ORF2 on host cell tropism of feline immunodeficiency virus. Virology (1996) 1.21
A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol (1995) 1.20
The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J Virol (1998) 1.19
Skeletal muscle metabolic and ionic adaptations during intense exercise following sprint training in humans. J Appl Physiol (1985) (2000) 1.19
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.19
Identification of feline immunodeficiency virus rev gene activity. J Virol (1991) 1.18
Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol (1990) 1.17
Detection of human herpesvirus-6 DNA in peripheral blood and saliva. J Med Virol (1990) 1.17
Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology (1993) 1.17
Two tRNAIle1 species from an extreme thermophile, Thermus thermophilus HB8: effect of 2-thiolation of ribothymidine on the thermostability of tRNA. Biochemistry (1985) 1.17
Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells. Lab Invest (1992) 1.16
A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J Virol (1993) 1.15
Spontaneously productive C-type retrovirus infection of fish cell lines. J Gen Virol (1991) 1.15
Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr (2001) 1.15
Myristoylation-dependent binding of HIV-1 Nef to CD4. J Mol Biol (1994) 1.15
Serodiagnosis of Toxoplasma gondii infection in cats by enzyme-linked immunosorbent assay using recombinant SAG1. Vet Parasitol (2001) 1.14